AFS
BVS icon

Anderson Financial Strategies’s Bioventus BVS Stock Holding History

Anderson Financial Strategies’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.85M Sell
172,900
-40,308
-19% -$338K 1.02% 22
2025
Q4 		$1.59M Buy
213,208
+78,488
+58% +$564K 0.92% 26
2025
Q3 		$901K Buy
+134,720
New +$935K 0.53% 29

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Anderson Financial Strategies's BVS Position: Q1 2026 in Review

Anderson Financial Strategies reduced its Bioventus (BVS) stake by 19% in Q1 2026, selling an estimated $338K and leaving 172,900 shares worth $1.85M. The position accounts for 1.02% of the portfolio, ranked #22.

Anderson Financial Strategies first reported a position in BVS in Q3 2025 and has held it in 3 quarters since. 157 funds tracked by Wall St. Rank hold BVS as of Q1 2026.

  • Anderson Financial Strategies held 172,900 shares of Bioventus worth $1.85M as of Q1 2026.
  • Anderson Financial Strategies sold 40,308 Bioventus shares in Q1 2026, an estimated $338K.
  • Bioventus made up 1.02% of Anderson Financial Strategies's portfolio in Q1 2026, its #22 holding.
  • Anderson Financial Strategies first reported a position in Bioventus in Q3 2025 and has held it in 3 quarters since.
  • 157 funds tracked by Wall St. Rank held Bioventus as of Q1 2026.

Based on Anderson Financial Strategies's 13F filing for Q1 2026, filed 15 May 2026.